FindTreatment.gov
Find state-licensed treatment near you for addiction and substance use disorder.
Related Articles
Transperineal vs Transrectal Prostate Biopsy: Trial Findings and Discussion – Badar Mian
In this follow-up discussion, Badar Mian and E David Crawford delve deeper into the implications of clinical trials comparing transperineal (TP) and transrectal (TR) prostate…
Bladder Cancer Breakthroughs in SunRISe-1, AMBASSADOR, and VOLGA Trials – Maria De Santis
Alicia Morgans interviews Maria De Santis about three studies: the SunRISe-1 trial for non-muscle-invasive bladder cancer, the AMBASSADOR study on adjuvant pembrolizumab for muscle-invasive urothelial…
STAT Madness Application
Enter to compete in this year’s STAT Madness! STAT Madness is a bracket-style tournament to find the best innovations in science and medicine from
FDA Grand Rounds
Highlights monthly webcast presentations for CE credit by FDA scientists from across agency on their cutting-edge scientific research
Jam Session Registration
We are thrilled to share our new season of the Johns Hopkins Center for Health Equity (CHE) Jam Sessions! CHE invites speakers from a variety of research…
Global Reach
Bringing Radioligand Therapy (RLT) Clinical Trials to Your Fingertips We are uniquely positioned at the heart of Theranostics. We’re dedicated to increasing awareness about Theranostics…
Concluding Thoughts on the Context of Physical Activity and Sedentary Behavior: Episode 6
In this conclusive sixth episode of our mini-series on the context of sedentary behavior and physical activity, we recap the importance of understanding thes…
Advances in Staging and Personalized Radiation Therapy for High-Risk Localized Prostate Cancer – Leslie Ballas
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Leslie…
Managing Nonmetastatic Castration-Resistant Prostate Cancer – Zachary Reardon
Zach Klaassen and Zach Reardon delve into the nuances of managing nonmetastatic castration-resistant prostate cancer (nmCRPC) in clinical practice. Dr. Reardon discusses the evolving landscape…